Previous Article | Next Article ![]()
Journal of Virology, June 2006, p. 5740-5746, Vol. 80, No. 12
0022-538X/06/$08.00+0 doi:10.1128/JVI.00169-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Jennifer R. Kent,2,
Brandon Placek,1
Kelly A. Whelan,1
Charles M. Hollow,2
Ping-Yao Zeng,1
Nigel W. Fraser,2 and
Shelley L. Berger1*
Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania,1 Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania2
Received 25 January 2006/ Accepted 22 March 2006
Human herpes simplex virus 1 (HSV-1) is a double-stranded DNA virus that causes facial, ocular, and encephalitic disease in humans. Previous work showed that the genome of HSV-1 is associated with acetylated and methylated histones during lytic infection. However, the physiological role of histone modifications in lytic infection of HSV-1 is unclear. We examined the role of protein methylation in lytic infection of HSV-1 using a protein methylation inhibitor, 5'-deoxy-5'-methylthioadenosine (MTA). We found that MTA strongly reduces the transcription and replication of HSV-1. Moreover, MTA treatment decreases the level of trimethylation of lysine 4 in histone H3 (H3K4me3) on the HSV-1 genome. These results suggest that protein methylation, and in particular, histone methylation, is involved in the lytic infection of HSV-1. To delineate the underlying mechanism, we investigated the role of two H3K4 methyltransferases, Set1 and Set7/9, in the lytic infection of HSV-1. Using small interference RNA, we found that the reduction of Set1, but not Set7/9, reduces the transcription and replication of HSV-1 and specifically decreases H3K4me3 on the virus genome. These results indicate that H3K4me3 mediated by Set1 is required for optimal gene expression and replication of HSV-1 during lytic infection and suggest that this pathway could be a potential point of pharmacological intervention during HSV-1 infection.
J.H. and J.R.K. contributed equally to this study.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|